GHK-Cu vs Matrixyl compares two of the most common anti-aging skincare peptides. GHK-Cu is a natural copper-binding tripeptide, and the original Matrixyl is palmitoyl pentapeptide-4, a lab-made collagen fragment.[2][3] Both boost collagen in lab dishes.[1][3] Matrixyl’s original ingredient has the stronger published human trial: 93 women over 12 weeks, against placebo. Peer-reviewed human evidence for topical GHK-Cu remains thin.[3][7] No study has compared them head to head.
For the wider picture, see our peptide basics hub and the GHK-Cu profile.
GHK-Cu vs Matrixyl at a glance
| GHK-Cu (copper tripeptide-1) | Matrixyl (palmitoyl pentapeptide-4) | |
|---|---|---|
| What it is | Glycine-histidine-lysine bound to copper; found in human blood[2] | Synthetic KTTKS collagen fragment with a fatty acid attached[3] |
| Peptide family | Carrier peptide (delivers copper)[4] | Signal peptide[4] |
| Lab evidence | Stimulates collagen in fibroblast cultures[1] | Designed to stimulate collagen production[3] |
| Best human trial | Randomized trial after laser resurfacing, mostly negative[5] | 93-woman, 12-week split-face trial, positive vs placebo[3] |
| Independence of research | Much of the literature from GHK’s discoverer[2] | Main trial run by the developer, Procter & Gamble[3] |
| Injectable use | Popular but unstudied; FDA safety concerns[12] | Not used as an injection |
| Status | Cosmetic ingredient[13] | Cosmetic ingredient[13] |
How GHK-Cu works
GHK was first isolated from human plasma and binds copper tightly.[2] In 1988, researchers found that GHK-Cu stimulated collagen synthesis in skin fibroblast cultures.[1] Reviews by its discoverer report effects on many genes involved in tissue repair and antioxidant defense,[2] but those claims come largely from one research group.
How Matrixyl works
Matrixyl’s active, pal-KTTKS, is a five-amino-acid piece of type I procollagen. The idea is that collagen fragments act as a “repair needed” signal that prompts skin cells to make more matrix.[3] On its own, KTTKS barely crosses skin because it is so water-soluble, so a palmitoyl (fatty acid) chain is added to make it more skin-friendly.[10]
A later product, Matrixyl 3000, combines palmitoyl tripeptide-1 (pal-GHK) with palmitoyl tetrapeptide-7.[8] So Matrixyl 3000 actually contains a fatty-acid version of the GHK peptide, without copper.
Reading the label: which version are you buying?
Ingredient lists use standardized INCI names rather than trade names, so it helps to know what to look for:
- Copper tripeptide-1 is GHK-Cu.[2]
- Palmitoyl pentapeptide-4 is the original Matrixyl peptide, pal-KTTKS.[3][9]
- Palmitoyl tripeptide-1 plus palmitoyl tetrapeptide-7 together indicate Matrixyl 3000.[8]
Two practical points follow. First, a “Matrixyl 3000” product contains a GHK-based peptide, but without the copper that defines GHK-Cu, so it is not a copper peptide product.[8] Second, labels almost never state the percentage of each peptide. In the main pal-KTTKS trial, the peptide was present at just 3 parts per million in the moisturizer, which shows how little peptide a formula may contain and still be tested.[3]
Both peptides are usually applied once or twice daily as part of a routine, and the trials that exist ran for 8 to 12 weeks, so judging results sooner than that is premature.[3][9]
Does either reach the right layer of skin?
Skin is a strong barrier, and both peptides are large by skincare standards. A 2026 study in 3 women detected the two Matrixyl 3000 peptides throughout the outer skin layer (stratum corneum), with levels falling with depth, mainly between cells rather than inside them.[8] That shows the peptides enter the outer layer; it does not show how much reaches the living dermis where collagen is made. Comparable human data for topical GHK-Cu are limited.[6]
The human evidence compared
Matrixyl
- 2005, US: in a double-blind, placebo-controlled, split-face trial, 93 white women aged 35 to 55 used a moisturizer with 3 ppm pal-KTTKS on one side and the plain moisturizer on the other for 12 weeks. Wrinkles and fine lines improved significantly more on the peptide side, by both image analysis and expert graders, and it was well tolerated.[3] The study was run by Procter & Gamble.
- 2023, Indonesia: in a 21-woman, 8-week double-blind trial, palmitoyl pentapeptide-4 cream looked better than an argireline cream and placebo for crow’s feet. The authors called it an initial study.[9]
GHK-Cu
- The well-known results were never peer-reviewed. Frequently quoted improvements in women using copper peptide creams come from conference presentations and unpublished reports.[2]
- The one published randomized skin trial was mostly negative. After CO2 laser resurfacing, a copper tripeptide cream did not improve redness, wrinkles or skin quality on objective measures.[5]
- Reviews agree evidence is thin. A 2025 review noted a lack of clinical anti-wrinkle studies,[6] and a 2026 systematic review found only two randomized trials among 20 studies.[7]
Side effects and safety
- Topical use: pal-KTTKS was well tolerated in its main trial.[3] A 2026 safety framework from P&G scientists found palmitoyl pentapeptide-4 resembled skin matrix proteins without signals for toxins or allergens.[11] The published topical GHK-Cu trials have not flagged major safety problems, but there are few of them.[5][7]
- Injected GHK-Cu: FDA says compounded injectable GHK-Cu may pose a risk of immune reactions from clumping and peptide-related impurities, and that human safety data are limited.[12] See our BPC-157 vs GHK-Cu comparison for more on injected use.
Legal status and cost
Both are legal cosmetic ingredients that do not need FDA approval before sale. A product that claims to change the body’s structure or function, such as “rebuilds collagen,” can legally be a drug.[13] Neither is an approved drug. Price depends on the product, and labels rarely give the peptide percentage. The peptide cream vs serum guide covers how the base formula affects what you get.
Which might suit you?
Questions worth asking a dermatologist:
- Do you want the ingredient with the best controlled trial? That points to pal-KTTKS (Matrixyl).
- Are you comparing copper peptides with retinoids? See copper peptides vs retinol.
- Are your lines mostly from facial expressions? Muscle-targeting peptides are a different category; see Matrixyl vs argireline.
The verdict
Matrixyl has the edge on published human evidence, mainly from one company-run trial of 93 women.[3] GHK-Cu has more intriguing lab biology and a bigger online following, but its peer-reviewed skin results are thin and partly negative.[5][7] Both are reasonable cosmetic ingredients to try with modest expectations. Injected GHK-Cu is a separate, unstudied practice.
